The effects of aldosterone and mineralocorticoid receptor (MR) blockers on presympathetic neurons in the rostral ventrolateral medulla (RVLM) are well studied. To directly investigate whether aldosterone, eplerenone (an MR blocker), FAD286 (an aldosterone synthase inhibitor) and benzamil (an epithelial sodium channel (ENaC) blocker) affect RVLM neurons, we examined changes in the membrane potentials (MPs) of bulbospinal RVLM neurons using the whole-cell patch-clamp technique during superfusion with these drugs to brainstem-spinal cord preparations. Aldosterone superfusion (0.1 lmol/l) depolarized the RVLM neurons. In contrast, eplerenone superfusion (1 lmol/l) hyperpolarized them. To evaluate the existence of aldosterone, FAD286 superfusion (10 lmol/l) was performed, and the RVLM neurons became hyperpolarized during FAD superfusion. These data suggest that MRs exist and that aldosterone is synthesized in the brainstem. Benzamil superfusion (1 lmol/l) hyperpolarized the RVLM neurons. To clarify whether aldosterone, eplerenone, FAD286 and benzamil acted directly on the RVLM neurons, a lowCa 2 þ , high-Mg 2 þ solution was used to block the synaptic input to the RVLM neurons, and the above-mentioned drugs were added during the low-Ca 2 þ superfusion. During the aldosterone superfusion, the RVLM neurons became depolarized, and they became hyperpolarized during eplerenone, FAD286 or benzamil superfusion. Importantly, when aldosterone was superfused after the benzamil solution, the MPs of the RVLM neurons did not depolarize. These results suggest that MRs are present in the RVLM neurons and that aldosterone is synthesized in the RVLM. The RVLM neurons themselves possess ENaCs, and ENaCs are the underlying mechanism by which aldosterone activates RVLM neurons. Hypertension Research (2013) 36, 504-512; doi:10.1038/hr.2012.224; published online 31 January 2013Keywords: aldosterone; benzamil; FAD286; RVLM neurons; whole-cell patch clamp
INTRODUCTIONThe actions of aldosterone include vasoconstriction, vascular fibrosis, endothelial dysfunction, and sodium reabsorption and retention. These actions contribute to hypertension. However, recently, many studies have demonstrated the relationship between aldosterone and sympathetic nerve activity. In fact, aldosterone has been shown to cross the blood-brain barrier relatively easily, 1 as clarified using the model developed by Gomez-Sanchez et al. 2 showed that the intracerebroventricular infusion of antagonists of the mineralocorticoid receptor (MR), at a dose that had no effect systemically, lowered blood pressure. Intracerebroventricular infusion of aldosterone increased blood pressure, 3 and MRs were found in the brain. 4 Furthermore, aldosterone is involved in remodeling after myocardial infarction, and central blockade of aldosterone has been shown to attenuate cardiac remodeling. 5,6 Recent studies have demonstrated the existence of an aldosterone system in the brain, 4 and an increase in [Na þ ] in cerebrospinal fluid